OXFORD, Conn.--(BUSINESS WIRE)--A dramatic breakthrough in manufacturing technology by BrachySciences (Booth #129) will be introduced at the 2008 World Congress of the American Brachytherapy Society being held in Boston, May 4-6. The new manufacturing technology has lead to the development of AnchorSeed™, the first major clinical innovation for real-time applicator users. AnchorSeed’s unique patent pending design is intended to give existing low dose rate prostate brachytherapy sources the ability to maintain their position within tissue, thereby allowing physicians to confidently place seeds in more strategic and beneficial locations than in the past. It is designed for use both with Mick® applicators as well as with pre-loaded needles.
